RTW Investments’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,975,554
Closed -$11.7M 93
2022
Q2
$11.7M Hold
3,975,554
0.3% 53
2022
Q1
$35M Hold
3,975,554
0.72% 40
2021
Q4
$63.8M Hold
3,975,554
0.93% 32
2021
Q3
$83.2M Buy
3,975,554
+1,428,629
+56% +$34.4M 1.26% 27
2021
Q2
$68.4M Buy
2,546,925
+532,525
+26% +$15.6M 1.03% 28
2021
Q1
$64.2M Buy
2,014,400
+757,991
+60% +$18.4M 1% 32
2020
Q4
$28.7M Buy
1,256,409
+1,110
+0.1% +$25.6K 0.48% 49
2020
Q3
$31.6M Buy
1,255,299
+9,483
+0.8% +$259K 0.76% 36
2020
Q2
$34.8M Buy
+1,245,816
New +$21.6M 0.98% 31

Other funds holding MGNX

RTW Investments's MGNX Position: Q3 2022 in Review

RTW Investments sold out of MacroGenics (MGNX) in Q3 2022, closing a stake of 3,975,554 shares — an estimated $11.7M sold.

RTW Investments first reported a position in MGNX in Q2 2020 and held it in 9 quarters. The position peaked at $83.2M in Q3 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q3 2022.

  • RTW Investments reported no remaining MacroGenics position as of Q3 2022 after selling out during the quarter.
  • RTW Investments sold 3,975,554 MacroGenics shares in Q3 2022, an estimated $11.7M.
  • RTW Investments first reported a position in MacroGenics in Q2 2020 and held it in 9 quarters.
  • RTW Investments's MacroGenics position peaked at $83.2M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.